__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
You can access the MAYZENT resources for patients below, which you can use with your SPMS patients. The materials are designed to help them manage their symptoms, better understand their disease and improve doctor–patient communication.
If you would like to receive printed copies of any of these materials, please contact your local MAYZENT key account manager.
INTRODUCTION TO MAYZENT
Patient resource to explain how MAYZENT works and how MAYZENT can help SPMS patients with active disease.
BEFORE YOU START MAYZENT
Patient resource to provide details around pre-initiation requirement with MAYZENT for SPMS patients with active disease.
STARTING TREATMENT WITH MAYZENT
Patient resource to provide details around the treatment initiation process and requirements with MAYZENT for SPMS patients with active disease.
CONTINUING TREATMENT WITH MAYZENT
Patient resource to provide details around ongoing monitoring and adherence requirements while on MAYZENT.
MAYZENT DISCUSSION GUIDES TO SUPPORT HCP DISCUSSIONS WITH PATIENTS
Guides to support discussions between HCPs and patients prescribed MAYZENT, introducing the treatment and providing details on pre-initiation, starting and continuing treatment. Included is one discussion guide for HCP use only, providing greater detail on each topic, and one discussion guide for use with patients.
Indication: MAYZENT is indicated for the treatment of adult patients with SPMS with active disease evidenced by relapses or imaging features of inflammatory activity.1
SPMS, secondary progressive multiple sclerosis.
Reference:
- MAYZENT (siponimod) Summary of Product Characteristics.
